等待开盘 11-06 09:30:00 美东时间
-3.010
-4.14%
11月4日,伊克力西斯(EXEL)收涨3.11%,报72.31美元,成交额2.79亿美元,市值176.44亿美元。 行情数据 • 开盘价:70.11美元 • 最...
11-04 05:45
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从50美元升至51美元;HC Wainwright & Co.:上调伊诺维奥制药评级至"买入",目标价5美元
11-03 18:20
As of Nov. 2, 2026, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices g...
11-02 21:45
今日重点评级关注:Canaccord Genuity:维持Viking Therapeutics"买入"评级,目标价从106美元升至118美元;Canaccord Genuity:维持Aclaris Therapeutics"买入"评级,目标价从10美元升至13美元
11-02 18:53
Barclays analyst Etzer Darout maintains Exelixis (NASDAQ:EXEL) with a Equal-Weight and raises the price target from $49 to $54.
10-30 22:23
华盛资讯10月30日讯,伊克力西斯公布2026财年Q3业绩,公司Q3营收6.59亿美元,同比增长10.2%,归母净利润2.18亿美元,同比增长12.7%。
10-30 06:45
Exelixis (NASDAQ:EXEL) affirms FY2026 sales outlook from $2.500 billion-$2.550 billion to $2.500 billion-$2.550 billion vs $2.549 billion estimate.
10-30 04:14
Exelixis (NASDAQ:EXEL) reported quarterly earnings of $0.94 per share which beat the analyst consensus estimate of $0.80 by 17.5 percent. This is a 20.51 percent increase over earnings of $0.78 per share from the same period last year. The company reported quarterly sales of $658.696 million which b...
10-30 04:09
10月28日,伊克力西斯(EXEL)收涨0.37%,报65.35美元,成交额9330.27万美元,市值161.93亿美元。 行情数据 • 开盘价:64.7美元...
10-28 04:47
10月27日,伊克力西斯(EXEL)收涨0.9%,报65.11美元,成交额1.09亿美元,市值161.33亿美元。 行情数据 • 开盘价:64.85美元 • 最...
10-27 04:47